Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries.

OBJECTIVES This study examines the risk of acute myocardial infarction (MI) conferred by the metabolic syndrome (MS) and its individual factors in multiple ethnic populations. BACKGROUND The risk of the MS on MI has not been well characterized, especially in multiple ethnic groups. METHODS Participants in the INTERHEART study (n = 26,903) involving 52 countries were classified using the World Health Organization (WHO) and International Diabetes Federation (IDF) criteria for MS, and their odds ratios (ORs) for MI were compared with the individual MS component factors. RESULTS The MS is associated with an increased risk of MI, both using the WHO (OR: 2.69; 95% confidence interval [CI]: 2.45 to 2.95) and IDF (OR: 2.20; 95% CI: 2.03 to 2.38) definitions, with corresponding population attributable risks of 14.5% (95% CI: 12.7% to 16.3%) and 16.8% (95% CI: 14.8% to 18.8%), respectively. The associations are directionally similar across all regions and ethnic groups. Using the WHO definition, the association with MI by the MS is similar to that of diabetes mellitus (OR: 2.72; 95% CI: 2.53 to 2.92) and hypertension (OR: 2.60; 95% CI: 2.46 to 2.76), and significantly stronger than that of the other component risk factors. The clustering of > or =3 risk factors with subthreshold values is associated with an increased risk of MI (OR: 1.50; 95% CI: 1.24 to 1.81) compared with having component factors with "normal" values. The IDF definition showed similar results. CONCLUSIONS In this large-scale, multi-ethnic, international investigation, the risk of MS on MI is generally comparable to that conferred by some, but not all, of its component risk factors. The characterization of risk factors, especially continuous variables, as dichotomous will underestimate risk and decrease the magnitude of association between MS and MI.

[1]  Sonia S. Anand,et al.  Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. , 2008, European heart journal.

[2]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[3]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ , 2002 .

[4]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[5]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[6]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .

[7]  M. Laakso,et al.  The Metabolic Syndrome Predicts Incident Stroke: A 14-Year Follow-Up Study in Elderly People in Finland , 2008, Stroke.

[8]  K. Hughes,et al.  Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels. , 1990, Journal of epidemiology and community health.

[9]  B. Bauduceau,et al.  Should we have more definitions of metabolic syndrome or simply take waist measurement? , 2007, Diabetes & metabolism.

[10]  R. Barski,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2009 .

[11]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[12]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[13]  H. Koyama,et al.  Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults. , 2007, Journal of atherosclerosis and thrombosis.

[14]  Clyne,et al.  Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. , 1993, Journal of hypertension.

[15]  A. Soltanian,et al.  The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. , 2007, International journal of cardiology.

[16]  M. Trevisan,et al.  Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. , 1998, American journal of epidemiology.

[17]  P Oja,et al.  Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. , 1997, American journal of epidemiology.

[18]  K. Yamagishi,et al.  Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke Among Japanese Men and Women , 2007, Stroke.

[19]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[20]  G. Reaven.  Banting lecture 1988 , 1997 .

[21]  M. Parrott,et al.  Hypertension management in adults with diabetes. , 2004, Diabetes care.

[22]  B. Howard,et al.  Diabetes and cardiovascular disease , 2000, Annual review of medicine.

[23]  S. Yusuf,et al.  Diagnostic strategies to detect glucose intolerance in a multiethnic population. , 2003, Diabetes care.

[24]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[25]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[26]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[27]  E. Ford.  The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. , 2004, Atherosclerosis.

[28]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[29]  Lin Sx,et al.  Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes--a preliminary analysis of the NHANES 1999-2002 data. , 2007 .

[30]  R. Hoffmann,et al.  Adiposity, fat distribution, and cardiovascular risk. , 1989, Annals of internal medicine.

[31]  E. Mannarino,et al.  Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. , 2004, Atherosclerosis.

[32]  Po Box,et al.  Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies , 2006 .

[33]  N. Marchionni,et al.  Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: What makes the difference? , 2007, Journal of endocrinological investigation.

[34]  S. Blair,et al.  Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. , 2004, Archives of internal medicine.

[35]  L. Tavazzi,et al.  A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. , 2006, American heart journal.

[36]  S. Pudaric,et al.  Cardiovascular Disease Risk Factors Among Older Black, Mexican‐American, and White Women and Men: An Analysis of NHANES III, 1988–1994 , 2001, Journal of the American Geriatrics Society.

[37]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). , 2000, Indian heart journal.

[38]  Rosa Solà,et al.  Metabolic Syndrome as a Cardiovascular Disease Risk Factor : Patients Evaluated in Primary Care , 2008 .

[39]  B. Paulweber,et al.  The Metabolic Syndrome Is a Stronger Risk Factor for Early Carotid Atherosclerosis in Women Than in Men , 2005, Stroke.

[40]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[41]  R. D'Agostino,et al.  Clustering of metabolic factors and coronary heart disease. , 1999, Archives of internal medicine.

[42]  E. Ford,et al.  A comparison of the prevalence of the metabolic syndrome using two proposed definitions. , 2003, Diabetes care.

[43]  H. Yokoyama,et al.  Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. , 2007, Diabetes research and clinical practice.

[44]  M. Stern.  Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis , 1995, Diabetes.

[45]  P. Savage,et al.  Metabolic Syndrome and Cardiovascular Disease in Older People: The Cardiovascular Health Study , 2006, Journal of the American Geriatrics Society.

[46]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.

[47]  A. Go,et al.  Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? , 2006, Journal of the American College of Cardiology.

[48]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[49]  Steven Hawken,et al.  Preventive cardiologyAbstractsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study , 2004 .

[50]  J. Hokanson,et al.  Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies , 1996, Journal of cardiovascular risk.

[51]  Susan Lin,et al.  Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes--a preliminary analysis of the NHANES 1999-2002 data. , 2007, Ethnicity & disease.